HGHTOP.com
[email protected]

US domestic UK Canada

PaymentBitcoinUSDT (TRC20)CashAppWestern UnionMoneyGramBank transferGoogle PayGet a Quote
Product reference
Product nameSomatropin Canada 150 IU HGH – Canada Peptides
Listed compoundSomatropin
Labeled quantity150 IU
CategoryHGH & Somatropin Products — USA
USA catalog

Somatropin Canada 150 IU HGH – Canada Peptides

$350.00

Sold out

Somatropin Canada 150 IU HGH by Canada Peptides is a human growth hormone product listed with somatropin, a recombinant peptide hormone composed of 191 amino acids. Each package contains 10 vials of 15 IU, providing a total labeled quantity of 150 IU HGH. This multi-vial presentation differs from the Somatropin Canada 75 IU product in total hormone quantity and vial strength. Review the original product photographs, manufacturer labeling, package contents and batch documentation to verify the specific formulation.

Somatropin HGH 150IU: Product Overview

Somatropin HGH 150IU by Canada Peptides is a human growth hormone (HGH) product listing containing somatropin, a recombinant peptide hormone composed of 191 amino acids. The catalog presentation specifies 10 vials of 15 IU each, providing a total labeled quantity of 150 IU.

Somatropin Canada 150 IU is the larger-strength package listing within the catalog's Somatropin Canada range. It differs from the separate 75 IU presentation in its total labeled growth hormone quantity and package specifications.

The name "Canada" is retained as part of the historical product identification. This product page remains within the USA HGH catalog and should not be interpreted as proof of Canadian manufacturing origin, regulatory approval or shipping location.

Somatropin Canada 150 IU Product Specifications

  • Product Name: Somatropin HGH 150IU
  • Catalog Brand: Somatropin Canada
  • Listed Manufacturer: Canada Peptides
  • Active Ingredient: Somatropin
  • Classification: Peptide hormone
  • Hormone Type: Human Growth Hormone (HGH)
  • Protein Structure: 191 amino acids
  • Total Labeled Quantity: 150 IU
  • Strength per Vial: 15 IU
  • Package Configuration: 10 vials x 15 IU
  • Product Presentation: Multi-vial HGH package
  • Concentration: Confirm after checking the actual formulation and vial volume
  • Storage: Follow verified product-specific instructions
  • Documentation: Confirm for the specific batch

Somatropin 150IU: Recombinant Human Growth Hormone

The listed active substance in Somatropin Canada 150 IU is somatropin, a recombinant form of human growth hormone consisting of 191 amino acids.

Human growth hormone is a protein hormone naturally produced by the anterior pituitary gland. It participates in physiological processes involving growth, protein metabolism, lipid metabolism and body composition.

Somatropin interacts with growth hormone receptors and influences downstream signaling involving insulin-like growth factor 1 (IGF-1).

Recombinant somatropin has established medical applications for certain growth hormone-related disorders. However, the stated ingredient and product strength do not independently establish the quality, regulatory status or clinical equivalence of a specific commercial formulation.

Somatropin HGH 150IU: 10 Vials of 15 IU

The Somatropin Canada 150 IU catalog entry is identified by its 10-vial package configuration.

According to the supplied product specifications, the listed package contains:

  • 10 individual somatropin vials
  • 15 IU labeled growth hormone per vial
  • 150 IU total labeled somatropin quantity
  • Canada Peptides manufacturer identification

The 150 IU designation describes the combined labeled quantity across all ten vials. It is not an individual injection amount or recommended daily dose.

The physical formulation, supplied diluent, vial concentration and preparation requirements should be confirmed from the actual product label and manufacturer documentation.

Somatropin Canada 150 IU vs Somatropin Canada 75 IU

Somatropin Canada 150 IU and Somatropin Canada 75 IU are separate HGH catalog presentations. Their differences should be evaluated using the exact labeled quantity, strength per vial, package configuration and documented formulation.

Somatropin Canada 150 IU

  • Total labeled quantity: 150 IU
  • 10 vials containing 15 IU each
  • Active ingredient: Somatropin
  • Listed manufacturer: Canada Peptides

Somatropin Canada 75 IU

The separate Somatropin Canada 75 IU listing identifies a package with a lower total labeled growth hormone quantity. Its vial count, individual vial strength and formulation should be checked against the specific product information.

Comparing Somatropin Products

When comparing the 150 IU and 75 IU listings, important factors include:

  • Total labeled somatropin quantity
  • Number of vials per package
  • Declared amount per vial
  • Pharmaceutical formulation
  • Vial volume and concentration
  • Preparation and storage requirements
  • Manufacturer and batch identification
  • Available product-specific documentation

A larger total IU quantity does not automatically mean a higher concentration, greater potency per unit or improved clinical effectiveness.

Somatropin Pharmacology and Half-Life

Somatropin is a peptide hormone that acts through growth hormone receptors and influences physiological signaling pathways involving IGF-1.

Its pharmacokinetic properties depend on the pharmaceutical formulation, route of administration and individual patient characteristics.

Some HGH catalogs describe a general active half-life of approximately 2.5–3 hours. This estimate should not be considered a verified pharmacokinetic measurement for Somatropin Canada 150 IU without supporting formulation-specific evidence.

The duration of biological effects cannot be determined from an elimination half-life estimate alone.

Somatropin HGH Storage and Handling

Somatropin is a temperature-sensitive biological substance. Appropriate storage and handling requirements depend on the specific pharmaceutical formulation.

Important information to verify includes:

  • Manufacturer-recommended storage temperature
  • Protection from light and temperature extremes
  • Product-specific preparation requirements
  • Approved diluent, if applicable
  • Storage conditions after preparation
  • Expiration date and batch identification

Storage instructions for another somatropin brand or formulation should not automatically be applied to this product.

Somatropin Safety and Medical Considerations

Somatropin is a biologically active hormone that requires appropriate medical evaluation and supervision.

Potential adverse effects associated with somatropin treatment include fluid retention, swelling, joint discomfort, changes in glucose regulation and other treatment-related reactions.

Medical contraindications and precautions for somatropin medicines may include active malignancy, severe diabetic retinopathy, certain acute critical illnesses and other conditions described in official prescribing information.

The labeled quantities of 15 IU per vial and 150 IU per package are product specifications, not individualized treatment recommendations.

Somatropin HGH 150IU Packaging and Documentation

Review the original product photographs below the main image to examine the packaging, vial presentation and manufacturer labeling associated with this listing.

Important product identification details include:

  • Somatropin Canada product identification
  • Canada Peptides manufacturer information
  • Somatropin active substance
  • 150 IU total labeled quantity
  • 15 IU strength per vial
  • 10-vial package configuration
  • Batch or lot number
  • Expiration date
  • Original package integrity
  • Product-specific handling instructions
  • Available batch or sample documentation

Historical laboratory reports and photographs should be evaluated using their original sample labels, dates and batch identifiers.

A previous laboratory report does not independently verify the identity, purity, potency or authenticity of a different supplied batch.

For historical documents held on this site, see the HGH laboratory report archive. The dates and sample labels are shown separately from current product information.

Frequently Asked Questions About Somatropin HGH 150IU

What is Somatropin Canada 150 IU HGH?

Somatropin Canada 150 IU is a recombinant human growth hormone catalog listing associated with Canada Peptides. The listed package contains ten vials of 15 IU each, totaling 150 IU.

Who manufactures Somatropin Canada 150 IU?

The supplied catalog identifies Canada Peptides as the manufacturer. Actual manufacturer identity should be confirmed through original packaging and supporting documentation.

What is the active ingredient in Somatropin HGH 150IU?

The listed active substance is somatropin, a recombinant form of human growth hormone composed of 191 amino acids.

How many vials are included in Somatropin Canada 150 IU?

The catalog specifies ten vials containing 15 IU of somatropin each, providing a total labeled quantity of 150 IU.

What does 150 IU mean on the package?

The 150 IU designation refers to the combined labeled quantity of growth hormone across all ten vials. It does not indicate a recommended treatment dose.

What is the difference between Somatropin Canada 150 IU and 75 IU?

The listings differ in total labeled somatropin quantity. The 150 IU presentation specifies ten vials of 15 IU, while the separate 75 IU product has a lower total labeled quantity. Its exact package configuration should be checked independently.

Does the name Canada confirm the country of manufacture?

No. The term "Canada" is part of the historical product naming in this catalog. The actual manufacturing origin must be verified from product-specific documentation.

Is Somatropin HGH 150IU listed in the USA catalog?

Yes. This product page belongs to the USA HGH collection. Its catalog placement does not independently establish the physical location of inventory or product origin.

What is the half-life of somatropin?

Somatropin pharmacokinetics depend on the formulation, administration route and individual patient characteristics. A product-specific half-life should be confirmed through appropriate documentation.

Does somatropin cause water retention?

Fluid retention is a recognized potential adverse effect of somatropin treatment. Claims that HGH never causes fluid retention should not be treated as medical guarantees.

How should Somatropin Canada 150 IU be stored?

Storage conditions should be verified against the manufacturer instructions applicable to the specific formulation and package.

What documentation should be checked?

Review the original manufacturer label, total strength, vial count, individual vial quantity, batch number, expiration date and available product-specific documentation.

Where can I find historical HGH laboratory reports?

Historical sample documentation can be reviewed in the HGH laboratory report archive. Each report should be assessed using its original date and sample identification.

How can I request information about Somatropin HGH 150IU?

Use the information request form on this page. The selected product is attached automatically. Enter your name, country, email and number of packages, and specify any questions about packaging, labeling or available documentation.

Related Product Guides

Related products

Related guides & information

Need help choosing a product?

Send an inquiry and get the information you need.

Request Information